文献速递临床微生物质量管理与危急值

Vitek-2 Compact 对葡萄球菌和肠球菌药敏试验的兽医方法学评价

Veterinary method evaluation of Vitek-2 compact for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.
PubMed 文献 · J Clin Microbiol · 2025-12-17

该研究以 Sensititre COMGP1F 肉汤微量稀释板为参考,评价 Vitek-2 Compact AST-GP81 卡对 51 株非金黄色/非路邓葡萄球菌、30 株金黄色葡萄球菌与路邓葡萄球菌及 34 株肠球菌的药敏表现。总体性能可接受,各菌群基本一致率至少 96%、分类一致率至少 94%,超过不低于 90% 的最低性能目标,但部分抗菌药物未达最低性能标准。

要点

  • Vitek-2 Compact 总体性能可接受,基本一致率至少 96%、分类一致率至少 94%。
  • 非金黄色/非路邓葡萄球菌中米诺环素完全不合格,克林霉素需离线确认试验。
  • 使用葡萄球菌头孢菌素折点时次要错误率不可接受,替代药物两法结果一致。

核心结论

  • Vitek-2 Compact 总体性能可接受,但部分抗菌药物未达最低性能标准。
  • 非金黄色/非路邓葡萄球菌的米诺环素完全不合格,阻碍患者报告。
  • 非金黄色/非路邓葡萄球菌的克林霉素需要离线确认试验。
  • 使用葡萄球菌头孢菌素折点时观察到不可接受的次要错误率,而替代药物在两法间结果一致。
  • 假中间葡萄球菌青霉素敏感结果需用诱导型 nitrocefin β-内酰胺酶试验确认,尤其使用 Sensititre COMPGP1F 板时。

研究设计与样本

  • 研究采用 Clinical Microbiology Procedures Handbook 描述的方法,以 Sensititre COMGP1F 肉汤微量稀释板为参考评价 Vitek-2 Compact AST-GP81 卡。
  • 测试菌株包括 51 株非金黄色/非路邓葡萄球菌、30 株金黄色葡萄球菌与路邓葡萄球菌、34 株肠球菌。

主要发现

  • 各菌群总体基本一致率至少 96%、分类一致率至少 94%,超过不低于 90% 的最低性能目标。
  • 非金黄色/非路邓葡萄球菌中米诺环素完全不合格。
  • 非金黄色/非路邓葡萄球菌中克林霉素需要离线确认试验。
  • 使用葡萄球菌头孢菌素折点时次要错误率不可接受。
  • 替代药物在两法间产生一致结果。

关键数值与推荐

  • 最低性能目标为一致率不低于 90%。
  • 总体基本一致率至少 96%、分类一致率至少 94%。
  • 假中间葡萄球菌青霉素敏感结果需用诱导型 nitrocefin β-内酰胺酶试验确认,尤其使用 Sensititre COMPGP1F 板时。
  • 两种测试板均需更新抗菌药物种类和稀释范围,以覆盖完整报告范围并支持在标质量控制测试和 One Health 跨部门转化。

临床怎么用

  • 兽医实验室可采用该方法学评价流程评估 Vitek-2 Compact 药敏性能。
  • 非金黄色/非路邓葡萄球菌米诺环素结果不可直接报告,克林霉素需离线确认。
  • 假中间葡萄球菌青霉素敏感结果需用诱导型 nitrocefin β-内酰胺酶试验确认。
  • 应推动更新兽医药敏测试板的抗菌药物种类与稀释范围。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Quality laboratory data are central to antimicrobial resistance detection in support of good patient care and for use in a One Health surveillance system. Here, we evaluated the Vitek-2 Compact AST-GP81 cards against Sensititre COMGP1F broth microdilution panels. A total of 51 Staphylococcus spp. not aureus/lugdunensis; 30 Staphylococcus aureus and Staphylococcus lugdunensis; and 34 Enterococcus spp. were selected for testing. Overall performance of the Vitek-2 Compact was acceptable, with at least 96% essential agreement and 94% categorical agreement across organism groups, exceeding the minimum performance goal of ≥90% agreement; however, several antimicrobials did not meet minimum performance standards. For Staphylococcus spp. not aureus/lugdunsis, minocycline failed entirely, precluding patient reporting and clindamycin required offline confirmatory testing. We observed unacceptable rates of minor errors if Staphylococcus cephalosporin breakpoints were used, whereas a surrogate agent produced consistent results between methods. Notably, we reaffirm that it is necessary to confirm any susceptible Staphylococcus pseudintermedius penicillin results with an induced nitrocefin β-lactamase test, especially if Sensititre COMPGP1F panels are used. Both test panels require updated antimicrobial offerings and dilution ranges to ensure a full range of test results can be reported. These updates should include consideration for test ranges that allow for on-scale quality control testing and translation across One Health sectors. Because antimicrobial susceptibility test results impact far more than single patient care in veterinary medicine, including human, herd, and environmental health, we advocate for the use of stringent antimicrobial susceptibility test method evaluation procedures in veterinary laboratories.IMPORTANCEAntimicrobial resistance is a critical threat to human and animal health globally. While our patient populations are different, we are connected by our shared environments and intertwined existence. As such, our antimicrobial susceptibility testing diagnostic and surveillance tools, as well as methods to evaluate their performance, should be uniform and capable of detecting critical antimicrobial resistance mechanisms. We evaluated the Vitek-2 Compact against our legacy Sensititre system and determined that accurate patient results and quality surveillance data could be produced using the Vitek-2 Compact. We used the evaluation method described in the Clinical Microbiology Procedures Handbook to demonstrate the utility of this method to peer veterinary laboratories. This publication importantly demonstrates that this evaluation procedure is scalable for veterinary applications. Furthermore, there is a need for updates to veterinary test panels as well as investments in and advancement of veterinary diagnostic tools, in support of a One Health approach to antimicrobial resistance detection.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Gefroh S, Meier B, Maddock K, et al. Veterinary method evaluation of Vitek-2 compact for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. J Clin Microbiol. 2025. PMID: 41406023. doi:10.1128/jcm.00961-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。